Table 3.

MMTV-Like env Sequence and Its Association with Clinicopathological Features in Breast Cancer Patients

	Non-Familial		Familial
	N= 50 (%)		N=30 (%)
	MMTV		MMTV
	Positive	Negative	Positive	Negative
	N=38(76)	N=12(24)	N=21(70)	N=9(30)
Age (years)
<45	12 (75)	4(25)	11(78.6)	3(21.4)
45	26(76.5)	8(23.5)	10(62.5)	6(37.5)
p-value	0.91		0.44
ER Status
Positive	31 (73.8)	11(26.2)	14(73.7)	5(26.3)
Negative	7 (87.5)	1 (12.5)	7(63.6)	4(36.4)
p-value	0.406		0.563
PR Status
Positive	29 (78.4)	8(21.6)	13(65)	7(35)
Negative	9 (69.2)	4 (30.8)	8(80)	2(20)
p-value	0.506		0.398
Tumor Size
<5cm	14 (60.9)	9 (39.1)	12 (66.7)	6 (33.3)
≥5cm	24 (88.9)	3 (11.1)	9(75)	3 (25)
p-value	0.012		0.626
Lymph Node
Positive	30 (78.9)	8(21.1)	17 (70.8)	7(29.2)
Negative	8 (66.7)	4(33.3)	4(66.7)	2(33.3)
p-value	0.385		1.000
Tumor Grade
G I, II	33(73.3)	12(26.7)	19(70.4)	8(29.6)
G III	5(100)	0.0(0)	2(66.7)	1(33.3)
p-value	0.319		1.000
Safety Margin
Positive	4(100)	0 (0.0)	2(66.7)	1(33.3)
Negative	34(73.9)	21(26.1)	19(70.4)	8(29.6)
p-value	0.56		1.000
Pathological Type
Invasive duct carcinoma	35 (76.1)	11(23.9)	17(65.4)	9(34.6)
Invasive lobular carcinoma	3(75)	1 (25)	4 (100)	0(0.0)
p-value	1.000		0.287
Menopausal Status
Premenopausal	15(71.4)	6(28.6)	14(70)	6(30)
Postmenopausal	23(79.3)	6(20.7)	7(70)	3(30)
p-value	0.52		1.000
Laterality
Right	24(77.4)	7(22.8)	12(80)	3(20)
Left	13(72.2)	5(27.8)	9(60)	6(40)
p-value	0.683		0.427
Stage
II	18(72)	7(28)	13(68.4)	6(31.6)
III+IV	20(80)	5(20)	8(72.7)	3(27.3)
p-value	0.508		0.804
Hormonal Therapy
Yes	8(88.9)	1(11.1)	5(50)	5(50)
No	30 (73.2)	11(26.8)	16(80)	4(20)
p-value	0.317		0.091